Overview

Ticagrelore Alone Post PCI

Status:
RECRUITING
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
After PCI for CCS patients, single center double blind randomization will be done and patients will receive aspirin 80 mg and clopidogrel 75 mg versus 90 mg two times daily of ticagrelor, for 6 months and MACE will be followed in registry of professor Kojuri cardiology clinic
Phase:
PHASE4
Details
Lead Sponsor:
Shiraz University of Medical Sciences
Treatments:
Aspirin
Clopidogrel
Ticagrelor